Axsome Therapeutics Inc — キャッシュフロー (NASDAQ:AXSM) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -78.46 M-108.23 M-116.51 M-145.08 M-128.41 M-93.41 M -93.41 M 投資活動によるキャッシュフロー -45.89 K-307.55 K-53.7 M-582 K-270 K-480 K -480 K 財務活動によるキャッシュフロー 42.41 M11.13 M284.58 M331.01 M57.84 M101.47 M 101.47 M フリーキャッシュフロー -78.5 M-108.53 M-117.21 M-145.66 M-128.68 M-93.89 M -93.89 M

ニュース

Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists

Axsome Therapeutics Priced For Perfection Ahead Of Auvelity's Alzheimer's Decision (AXSM)

Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists

Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?

Neurocrine Biosciences: The Song Remains The Same (NASDAQ:NBIX)

AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?

RBC Capital、Axsome Therapeutics株のOutperform評価を継続

RBC Capital reiterates Axsome Therapeutics stock rating at Outperform

Axsome TherapeuticsがThe Citizens Life Sciences Conferenceで戦略的成長計画を発表

Axsome Therapeutics at The Citizens Life Sciences Conference: Strategic Growth Plans

Axsome Therapeutics, Inc. (AXSM) Presents at Leerink Global Healthcare Conference 2026 Transcript

Leerinkカンファレンスにおけるアクソーム・セラピューティクス：戦略的成長と課題